NCT05651152 A Study to Investigate The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP441 in Sleep-deprived Healthy Participants Status COMPLETED Phase PHASE1
NCT05642442 A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's Disease Status COMPLETED Phase PHASE2
NCT05636111 Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer Status RECRUITING Phase PHASE1
NCT05631327 A JZP341 Study in Adult Participants With Advanced or Metastatic Solid Tumors Status TERMINATED Phase PHASE1
NCT05629702 ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids Status RECRUITING Phase PHASE2
NCT05580562 ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) Status RECRUITING Phase PHASE3
NCT05574504 Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline Therapy Status WITHDRAWN Phase PHASE2
NCT05558124 CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML Status RECRUITING Phase PHASE1
NCT05557045 A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815 Status RECRUITING Phase PHASE1
NCT05542407 ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer Status RECRUITING Phase PHASE1
NCT05485831 Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY Status RECRUITING Phase N/A
NCT05476939 Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0 Status RECRUITING Phase PHASE3
NCT05392374 Expanded Access Use of ONC201 in a Patient With Diffuse Intrinsic Pontine Gliomas Status NO_LONGER_AVAILABLE Phase N/A
NCT05391724 Safety and Pharmacokinetics of CMX001 in Impaired Hepatic Function and Healthy Subjects Status COMPLETED Phase PHASE1
NCT05288283 Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures Status TERMINATED Phase PHASE3
NCT05260528 CPX-351 vs Intensive Chemotherapy in Patients With de Novo Intermediate or Adverse Risk AML Stratified by Genomics Status RECRUITING Phase PHASE2
NCT05244239 Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer Status RECRUITING Phase PHASE1
NCT05229588 Lurbinectedin in Patients With Advanced Gastrointestinal Malignancies With DNA Repair Mutations Status COMPLETED Phase PHASE2
NCT05178316 A Study of JZP150 in Adults With Posttraumatic Stress Disorder Status COMPLETED Phase PHASE2